- Previous Close
11,130.00 - Open
11,000.00 - Bid 11,070.00 x --
- Ask 11,080.00 x --
- Day's Range
10,980.00 - 11,200.00 - 52 Week Range
10,980.00 - 15,900.00 - Volume
17,991 - Avg. Volume
12,176 - Market Cap (intraday)
168.854B - Beta (5Y Monthly) 0.32
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Apr 28, 2025 - May 2, 2025
- Forward Dividend & Yield 300.00 (2.70%)
- Ex-Dividend Date Dec 27, 2024
- 1y Target Est
21,000.00
Whan In Pharm Co.,Ltd. manufactures and sells various pharmaceuticals products in South Korea. The company offers anti-depressants, anti-psychotics, nootropics and anti-dementia, anti-epileptics, cardiovascular, gastrointestinal, antibiotics, antiviral agents, antihistamines, anti-inflammatory and analgesics, metabolic disorders, respiratory, central nervous system, other drug products. The company was founded in 1978 and is headquartered in Seoul, South Korea.
www.whanin.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: 016580.KS
View MorePerformance Overview: 016580.KS
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 016580.KS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 016580.KS
View MoreValuation Measures
Market Cap
168.85B
Enterprise Value
116.69B
Trailing P/E
7.22
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.65
Price/Book (mrq)
0.45
Enterprise Value/Revenue
0.45
Enterprise Value/EBITDA
3.29
Financial Highlights
Profitability and Income Statement
Profit Margin
9.01%
Return on Assets (ttm)
3.25%
Return on Equity (ttm)
6.37%
Revenue (ttm)
259.6B
Net Income Avi to Common (ttm)
23.38B
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
52.58B
Total Debt/Equity (mrq)
0.11%
Levered Free Cash Flow (ttm)
-20.16B